Stock Image

Current Topics in Extrapyramidal Disorders (Journal of Neural Transmission. Supplementa)

n/a

0 ratings by Goodreads
ISBN 10: 3211815708 / ISBN 13: 9783211815700
Published by Springer, 1980
Used Condition: Fair
Buy Used
Price: US$ 20.48 Convert Currency
Shipping: US$ 0.00 Within U.S.A. Destination, Rates & Speeds
Add to basket

30 Day Return Policy

Offered By

Better World Books
Mishawaka, IN, U.S.A.

5-star rating

AbeBooks Seller Since August 3, 2006

About this Item

Former Library book. Shows definite wear, and perhaps considerable marking on inside. Bookseller Inventory # GRP70943184

Quantity Available: 1

Ask Seller a Question

Bibliographic Details

Title: Current Topics in Extrapyramidal Disorders (...

Publisher: Springer

Publication Date: 1980

Book Condition: Fair

Edition: 1st Edition.

About this title

Synopsis:

The scientific work of Walther Birkmayer is grounded on his ability to turn what was often a mass of clinical details into the basis for a hypothesis for a new therapeutic approach toward solving the problems of a patient's illness. Birkmayer first became known when, during the Second World War, he built up a clinic for brain injuries in Vienna, in which over 3000 patients were treated. The study of changes in the autonomic functions of the nervous system in these patients as well as the problems of rehabilitation were published in a monograph, "Hirn­ verletzungen". Consequently, this was his major scientific interest during the post-war years. His book, "Klinik und Therapie der vegetativen Funktionsstorungen" published with W. Winkler, brought Birkmayer recognition in the German-speaking world. In 1954 he took over the Neurological Department of the Geriatric Hospital of Vienna in Lainz, where he remained until his retirement in 1975. International acclaim followed his breakthrough with the clinical application of L-DOPA in Parkinson's disease. Birkmayer, as a strong adherent to the scientific interpretation of neurological and psychiatric disease, has encouraged multidisciplinary research. This is reflected in his establishment of the former Ludwig Boltzmann­ Institute of Neurochemistry, in which pharmacological, biochemical and histopathological research into neuropsychiatric diseases was performed under one roof. Further to his initial work on L-DOPA, Birkmayer has been in the forefront of supplementary parkinsonian therapy using enzyme inhibitors: benserazide in 1967, unselective monoamine oxidase inhibitors in 1962 and deprenyl in 1975.

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Terms of Sale:

100% refunds guaranteed, no questions asked.


Shipping Terms:

We ship daily!

List this Seller's Books

Payment Methods
accepted by seller

Visa Mastercard American Express